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Glucocorticoid hormones are widely used clinically to suppress the rejection of trans- 
planted organs, a  reaction in which lymphocyte-mediated cellular immunity, rather 
than antibodies, is thought to play an important role (1), 
Cellular immune reactions may be divided into at least two major phases. The first 
phase is considered to be the inductive or sensitization phase which involves antigen- 
induced lymphocyte differentiation and proliferation. The second is the effector phase 
and comprises the expressions of the immune reaction, such as lymphocyte-mediated 
injury to target cells.  Thus, glucocorticoid hormones could depress cellular immune 
reactions by inhibiting the induction of sensitization and/or by suppressing the effector 
mechanism of sensitized lymphocytes. Gabrielsen and Good (2) have recently reviewed 
the immunosuppressive properties of adrenal steroid hormones and other chemicals. 
They noted the difficulty of distinguishing between the establishment  of sensitivity 
and its expression, in systems used to study cellular immunity reactions. Hence, it has 
been difficult to assign the immunosuppressive action of glucocorticoids to the induc- 
tive and/or the effector phases. Nevertheless, Gabrielsen and Good felt that, in addi- 
tion to the remarkable effects of glucoeorticoids in inhibiting the expression of sensiti- 
zation, there was some evidence to indicate that cortisone  administered  around the 
time of sensitization probably modifies the sensitization process itself (2). 
To analyze the effects of glucocorticoids on the induction of sensitization as 
well  as  on the  effector phase  of cellular  immunity,  we  employed an  in vitro 
lymphocyte  antifibroblast  reaction  (3-5).  Normal  rat  lymphocytes  were 
sensitized  against  foreign  rat  or mouse  embryonic fibroblasts  in  cell  culture. 
Sensitized  lymphocytes were  then transferred  to target fibroblast monolayers 
and  fibroblast  injury  was  measured.  Prednisolone  or  hydrocortisone  was 
added  to  the  tissue  culture  medium  during  the  sensitization  phase  and/or 
during  the  cytolytic effector phase  of the lymphocyte-mediated reaction. 
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It  was  found that  these glucocorticoid hormones influenced each phase  of 
the lymphocyte anti-fibroblast reaction. The presence of a glucocorticoid during 
the induction phase led to a marked reduction in the total number of lympho- 
cytes  surviving sensitization. However,  the  population of  surviving 1)~npho- 
cytes contained a  greater proportion of large transformed cells, and after the 
hormone was  removed, was  able to  destroy several times more  target fibro- 
blasts  than could an equal number of  control-sensitized lymphocytes. 
Glucocorticoid hormones influenced the effector phase by inhibiting lympho- 
cyte-mediated damage  to  target  fibroblasts.  Inhibition occurred  at  concen- 
trations of hormone that did not affect the viability of the previously sensitized 
lymphocytes.  Thus,  prednisolone  and  hydrocortisone  appeared  to  suppress 
the  expression of the  cytolytic effects  of sensitized banphocytes, but did not 
interfere with  the induction of sensitization, a  process which they seemed to 
facilitate. 
Materials and Methods 
Glucocorticoids.--Stock  solutions  of  sterile  hydrocortisone  sodium  succinate  (Organon, 
Inc., West Orange, N. J.) and prednisolone sodium tetrahydrophthalate  (Ciba Corp., Summit, 
N. J.) were prepared in phosphate-buffered saline (PBS),  1  pH 7.2, and stored at concentrations 
of 0.1 and 1.0 mg/ml at 4°C. 
Fibroblast Monolayers.--Primary  cultures of fibroblasts were obtained from 16-day old in- 
bred C3It/eb mouse embryos or from 17-day old inbred Lewis or inbred Wistar rat embryos by 
trypsinization, as described elsewhere (3-6). Explanted fibroblasts were seeded in plastic Petri 
dishes (Falcon Plastics, Los Angeles, Calif.) in Waymouth's medium supplemented with 5% 
calf serum. Mter 4 days of incubation (37°C, 10% CO2 in moist air), the culture medium was 
replaced by lactaibumin hydrolysate in Earle's saline with 5% calf serum (LA) which was then 
changed every 4 days. Fibroblasts were transferred to sensitization cultures (3 X  106 fibro- 
blasts, 60 mm plastic Petri dishes) and target cultures (0.7 X  106 fibroblasts, 35 mm plastic 
Petri dishes) after x-irradlation (2000 R). Target fibroblasts were labeled 4-5 days before use 
with radioactive chromium by incubation with 51Cr as Na~CrO4 (Radiochemical Centre, 
Amersham, England) at a concentration of 2/zCi per target plate in 1 ml LA (5, 6). The radio- 
active medium was replaced by LA after 24 hr. 
Lymphocyte Cultures.--Inbred  Lewis rats were obtained from Microbiological Associates, 
Inc., Bethesda, Md. Inbred Wistar rats were supplied through the kindness of Mr. Shalom 
Joseph of the Department of Biodynamics of this Institute. Lymph nodes or spleens were re- 
moved from ether-anesthetized rats which weighed about 300 g. Cells were collected into cold 
PBS by gentle teasing (lymph nodes) or straining through a fine  wire mesh (spleens) as pre- 
viously described (3-6). Nucleated cells were counted and suspended in Dulbecco's modifica- 
tion of Eagle's medium with 20% horse serum (EM; Grand Island Biological Co., Berkeley, 
Calif.). Glucocorticoids  were added to EYI in the concentrations indicated in Results. 
Sensitization was induced by incubating  4 ml of suspensions  of lymphocytes with sensitizing 
fibroblast monolayers for 5 days. On the 3rd day of culture, 3 ml of EM was replaced by fresh 
EN[ which contained  the  added glucocortlcoid. After sensitization, the  lymphocytes  were 
collected by repeated pipetting of the culture medium, resuspended in fresh EM, and trans- 
1  Abbreviations used in  this paper: EM, Eagle's  medium; LA, lactalbumin hydrolysate; 
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ferred to target fibroblast cultures for assay of cytolytic activity. Large lymphocytes, small 
lymphocytes, and fibroblasts were distinguishable by their characteristic microscopic appear- 
ance. 
Assay of Lymphocyte-Mediated Cytolysis.--Injury  to fibroblasts was estimated  by the per 
cent of the total 51Cr which was released from target monolayers by  the action of sensitized 
lymphocytes, as described by Berke and associates (5) with minor modifications (6). Briefly, 
51Cr-labeled target monolayers were washed with LA and incubated with 1.5 ml of EM con- 
taining the sensitized lymphocytes.  A well-type sodium iodide crystal scintillation counter 
(Packard Instrument Co., Inc., Downers Grove, Ill.), was used to measure the relative amount 
of 51Cr released into the medium in each target culture. Each experimental value represents 
the mean of three target cultures. The standard error in these experiments was always less than 
2%, similar to that described by Berke and associates (7).  Spontaneous release of 51Cr from 
TABLE  I 
Effects of Pretreatlng C3It Target Fibroblasts with Prednisolone* 
Prednisolone  pretreatment of 
C3H fibroblasts 
Release of UCr 
In presence of Lewis  Spontaneous  anti-C3H lymphocytes 
#g/mt  %  % 
0  12  36 
0.5  13  36 
5  12  37 
50  12  37 
500  11  35 
* C3H target fibroblast monolayers were incubated for 24 hr with EM containing predniso- 
lone. 4 X  106 Lewis lymphocytes which had been sensitized against C3H fibroblasts were then 
cultured with the target fibroblasts for 20 hr in the absence of prednisolone. 
intact target fibroblasts was measured in triplicate in each experiment and the value was sub- 
tracted from each experimental result. The spontaneous release of 51Cr usually was between 5 
and 15%, and was not significantly influenced by incubation of the target monolayers with up 
to 10 X  106 unsensitized lymphocytes (6) or by the addition of hydrocortisone or prednisolone. 
To  learn whether lymphocyte-mediated cytolysis of fibroblasts might be influenced by 
treating the target fibroblasts with glucocorticoids, target fibroblasts were preincubated for 24 
hr with EM containing concentrations of prednisolone from 0.5 to 500 #g/ml. The prednisolone 
was removed and sensitized lymphocytes were added to the target fibroblast cultures. The 
spontaneous and lymphocyte-mediated release of 51Cr was measured after 24 hr of incubation. 
It was found (Table I) that pretreating the target fibroblasts with prednisolone had no sig- 
nificant effect on the release of 51Cr. 
RESULTS 
The Effects of Glucocorticoids on the Induction of Sensitization.--The  effects of 
prednisolone  and hydrocortisone  on  the  induction  of  small  lymphocytes  into 
sensitized effector cells were  studied by adding glucocorticoids  to the medium 
of  the  sensitization  cultures  and  measuring  the  number  of  lyrnphocytes  and 
their cytolytic  capacity  at  the  termination  of  the  sensitization period. 1058  GLUCOCORTICOIDS  AND  CELLULAR  IMMUNITY  IN  VITRO 
Fig. 1 shows the results of an experiment in which 50 X  106 Wistar rat lymph 
node cells  were sensitized  against  allogeneic Lewis  rat fibroblasts  in medium 
containing 0-100 #g/ml of prednisolone. 
It was found that the number of lymphocytes recoverable from the sensitiz- 
ing cultures was progressively reduced by the addition of increasing concentra- 
tions of prednisolone  (Fig.  1). Cytolytic capacity was measured by incubating 
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Fro. I. The effects of prednisolone on the induction of sensitization. Cultures of 50 X  106 
Wistar rat lymph node cells were sensitized against Lewis rat fibroblasts in the presence of 
prednisolone. The per cent of lymphocytes surviving sensitization was then counted. The per 
cent lysis of Lewis target fibroblasts by 1 X  106 of the sensitized lymphocytes was measured 
after 18 hr of incubation in the absence of prednisolone. 
1  X  106  washed,  sensitized  lymphocytes with  target  fibroblasts  for  18  hr. 
Lymphocytes which had been sensitized without added prednisolone or with a 
concentration of 0.1/zg/ml caused about 5 % lysis of target fibroblasts (Fig. 1). 
Sensitization  in the presence  of 1.0 and  10 ~g/ml was associated with  target 
fibroblast  lysis  of  23  and  28%.  Lymphocytes  sensitized  in  the  presence  of 
100 #g/ml of prednisolone showed no significant increase in cytolytic activity 
when compared with control cultures. 
Thus, prednisolone, at concentrations of 1 and 10/~g/ml was associated with 
both a  decrease in the number of recoverable lymphocytes and an increase  in 
their cytolytic capacity. ]:RUN  R.  COHEN~  LARY  STAVY,  AND  MICHAEL  FELDMAN  1059 
It  was  possible  that  the  augmented  cytolytic  capacity  resulting  from in- 
duction  in the presence of glucocorticoids was not related to sensitization  of 
lymphocytes against specific antigens,  but rather to a  nonspecific increase in 
cytotoxicity which  could  be manifested  against  fibroblasts  antigenically  un- 
related  to  the  sensitizing fibroblasts.  To test  this  possibility  (Fig.  2),  Lewis 
rat  spleen  cells were sensitized  against xenogeneic  C3H mouse fibroblasts in 
the  presence  of  concentrations  of  hydrocortisone  from 0  to  10  #g/ml.  The 
sensitized lymphocytes were collected and 1 X  106 were incubated with antigen- 
specific C3H  or with  syngeneic Lewis  target fibroblasts.  In this  experiment, 
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FIG. 2.  Target fibroblasts. The immunospecificity  of the effects of hydrocortisone on the 
induction of sensitization. Cultures of 27 X  106 Lewis rat spleen cells were sensitized against 
C3H mouse fibroblasts in the presence of hydrocortisone. Per cent lysis of antigen-specific  C3H 
and syngeneic  Lewis target fibroblasts by 1.2 X 106 of the sensitized lymphocytes was meas- 
ured after 6 hr of incubation in the absence of hydrocortisone. 
the release of 51Cr from target fibroblasts was measured after 6 hr to learn if 
augmented cytolysis could be demonstrated within the time of one lymphocyte 
generation.  It was found  (Fig.  2)  that Lewis spleen lymphocytes which were 
sensitized against  C3H fibroblasts in the  absence of hydrocortisone were un- 
able to cause significant lysis to target fibroblasts during  6 hr of incubation. 
However, lymphocytes which  were sensitized  in  the  presence of  1 #g/ml of 
hydrocortisone caused 20 % lysis of antigen-specific C3H target fibroblasts but 
no significant lysis of syngeneic Lewis target fibroblasts (Fig. 2). 
These results indicated  (a) that induction in the presence of hydrocortisone 
does  not  impair  the  immunospecificity of  the  effector phase,  and  (b)  that 
augmented cytolysis can be expressed within one generation after incubation 
in hydrocortisone. This finding argues against the possibility that sensitization 
takes place in the target culture in the absence of hydrocortisone. It also sug- 1060  GLUCOCORTICOIDS  AND  CELLULAR  IMMUNITY  IN  VITRO 
gests that augmented cytolysis is not merely the result of increased lymphocyte 
proliferation. 
The Ejects of Glucocorticoids on Lymphocyte Kinetics During Sensitization.- 
To  gain insight into the process by which  glucocorticoids appear to promote 
sensitization we measured the kinetics of the effects of glucocorticoids on the 
number  of lymphocytes and  their degree of transformation  during  induction. 
I00  o--o 
H  ydr° c °r tis°ne, 3Fcg/ml o----o 
Control  x--x  X----X 
X  X/x  \ 
~Totol  lymphocytes  t  o 
E  I-- 
~-  ...........  ~-  /, 
\\x\x,  Large  lymphocytes  /1// 
,  o/  \  1 I 
\\  / / 
o.,  l  g  4-  J  l 
0  I  2  3  4  5 
Sensitization  Phase(Days) 
Fzo. 3.  The effects of hydrocortisone on the cell kinetics of the sensitization phase. Cultures 
of 25 X  106 Lewis rat lymph node cells were sensitized against C3H mouse fibroblasts in con- 
trol medium and in the presence of hydrocortisone (3 #g/ml). On days 2, 3, 4, and 5, all the cells 
in two culture dishes were collected by using a trypsin solution and the lymphocytes, small and 
large, were counted. The indicated points represent the average number of cells counted in each 
pair of culture dishes. The numbers of cells did not differ by more than 12% in each of the pairs. 
Comparable results were  obtained in five  experiments in which  lymphocytes 
derived from lymph nodes or spleens were induced in medium containing  1-3 
#g/ml of hydrocortisone or prednisolone. Figs. 3  and 4  show the results of an 
experiment  in  which  Lewis  rat  lymph  node  cells were  seeded  on  sensitizing 
monolayers  of  C3H  fibroblasts with  or  without  3  ~g/ml  of  hydrocortisone. 
All the cells from two cultues plates were collected on days 2, 3, 4,  and 5  by 
using a  trypsin solution (0.3 %). The total number of viable lymphocytes and 
the  number  of  large  transformed  lymphocytes,  including  those  adherent  to 
fibroblasts, were counted. ][RUN R.  COHEN,  LARY STAVY, AND  MICHAEL  FELDMAN  1061 
The kinetics of changes in the lymphocyte population are shown in Fig. 3. 
In control medium, the total number of lymphocytes fell from 25  X  106 to a 
low point on day 3 of 10 X  106 cells and then increased to 19 X  106 on day 5. 
Large transformed lymphocytes began to appear in increasing numbers from 
day 3 (1 X  106)  to day 5 (6 X  106). In the presence of 3/zg/ml of hydrocorti- 
sone,  the  loss  in  total number of lymphocytes was  more marked and  there 
remained  only about  1  X  106 lymphocytes on day 4.  The total number of 
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FIG. 4.  The effects of hydrocortisone on the per cent of large lymphocytes during sensitiza- 
tion. The per cent of large lymphocytes found in the experiment shown in Fig. 3 was com- 
puted on days 2, 3, 4, and 5. Lysis of C3H target flbroblasts by 1 X  106 of these sensitized 
lymphocytes was measured after 18 hr. The lyric activity of the hydrocortisone-treated lympho- 
cytes was fourfold greater than that of the control lymphoeytes (20: 5). 
lymphocytes, however, increased to about 2  X  106 at the end of day 5.  The 
number of large lymphocytes fell to about 0.1  X  106 on day 3  and then rose 
to about 1.4 X  106 on day 5 (Fig. 3). 
Fig. 4 shows the per cent of large lymphocytes which appeared during the 
sensitization reaction presented in Fig. 3. The per cent of large lymphocytes 
was about the same in both hydrocortisone-treated and control cultures until 
day 3.  By day 5,  however, 63%  of the  hydrocortisone-treated lymphocytes 
and  only  36%  of  the  control  lymphocytes  appeared  as  large  transformed 
lymphocytes. 
At the termination of sensitization, 1 X  106 lymphocytes were transferred to 
target fibroblast monolayers. The lymphocytes which had been sensitized in 1062  GLUCOCORTICOIDS  AND  CELLULAR  IMMUNITY  IN  VITRO 
the presence of hydrocortisone produced fourfold more lysis than the sensitized 
control lymphocytes. These findings indicate that the presence of hydrocorti- 
sone  or prednisolone  is  associated with  a  marked decrease in the  number  of 
lymphocytes during  the initial stages of the induction  of sensitization.  How- 
ever,  the relative number of large 1)Tnphocytes among the  total lymphocyte 
population  rises  sharply  toward  the  end  of  the  induction  phase,  producing 
cultures  which  are richer  in  large  transformed lymphocytes than  are  control 
cultures.  This  suggests  that  glucocorticoids  may promote  the  selection  and 
proliferation of specifically reactive lymphocytes from among the initial popu- 
lation. 
TABLE II 
Augmented Cytolytic Effects of Equal Numbers of Large Lymphocytes 
Measured by Direct Cell Count 
Sensitization phase*  Lyric phase* 
Hydroeortisone 
No. of lymphocytes X  106 
Prelysis  Postlysis 
Total  Large  Total  Large 
Injured fibroblasts 
#g/ml  % 
0  1.9  0.5  1.2  0.4  4 
2  0.6  0.5  2.4  2.1  96 
* 28 X  106 Lewis spleen cells were sensitized against C3H fibroblasts. 
~: The indicated numbers of total and sensitized large lymphocytes were incubated with 
C3H target fibroblasts. After 18 hr the cultures were trypsinized and the numbers of viable 
lymphocytes and fibroblasts were counted. 
Augmented Cytolytic Effect Measured by Direct Cell Count.--The above results 
raised the question of whether the increase in the per cent of large transformed 
cells could account for the increased cytolytic effect of lymphocytes induced 
in  the  presence  of  glucocorticoids.  In  order  to  study  this,  Lewis  rat  spleen 
cells were sensitized against  C3H mouse fibroblasts with  or without  2 #g/ml 
of hydrocortisone  (Table II). The sensitized lymphocytes were collected and 
1.9 ;<  106 control lymphocytes and 0.6  X  106 treated lymphocytes (each popu- 
lation  containing  the same  number of  large lymphocytes,  0.5  X  106) were 
transferred  to  C3H  target  fibroblasts.  After  18  hr  of  incubation,  surviving 
fibroblasts and lymphocytes were collected by use of a trypsin solution. Viable 
fibroblasts and  lymphocytes were  counted.  It was found  in  this  experiment 
that 96 %  of the target fibroblasts were either completely lysed or made per- 
meable  to  eosine  Y  by  the  lymphocytes which  had  been  sensitized  in  the 
presence of hydrocortisone. Only 4 %  of the target fibroblasts were injured by 
lymphocytes which had been sensitized in the absence of hydrocortisone. The ]:RUN  R.  COHEN,  LARY  STAVY,  AND  MICHAEL  FELDMAN  1063 
number  of  nontreated  lymphocytes  seemed  to  decrease  slightly  during  the 
cytolytic reaction.  On the other hand,  the number of hydrocortisone-treated 
lylnphocytes increased fourfold during the reaction (Table II). 
Thus,  the  cytolytic  capacity  of  hydrocortisone-treated  lymphocytes  was 
greater than  that  of the nontreated  lymphocyte cultures,  although  each  cell 
population initially contained an equal number of large transformed lympho- 
cytes. Fibroblast injury was confirmed in  this experiment by direct count of 
target fibroblasts and,  therefore,  detection  of the  augmented cytolytic effect 
was not limited to the 5tCr method. 
TABLE III 
Effects of Preincubating Spleen Cells with Hydrocortisone* 
Sensitization phase of Lewis anti-C3H  Lyric phase~t 
Hydrocortisone  Recoverable cells (X 106) 
Preincubation 8 hr  5 day sensitization  Total cells  Large cells  Ratio of activity 
Izglml  Izglml 
3  3  0.6  0.2  3 
None  3  1.0  0.4  3 
0  0  7.3  1.4  1 
None  0  7.2  1.3  1 
* 25 X  106 Lewis spleen cells were preincubated for 8 hr or seeded directly on C3H fibro- 
blasts with or without hydrocortisone. 
1 X  106 sensitized spleen cells were transferred to C3H target fibroblasts for 20 hr. The 
ratio of activity was computed by comparing the per cent lysis of each culture to the control 
cultures which were neither preincubated nor treated with hydrocortisone. 
The Effects of Preincubating Lymphocytes with Glucocorticoids Before Exposure 
to Fibroblast Anligens.--Experiments  were  carried  out  to  study the  effect of 
preincubating  lymphocytes  with  glucocorticoids  before  exposing  them  to 
the  sensitizing  fibroblasts.  Table  III shows  the  results  of  an  experiment  in 
which Lewis spleen cells were either preincubated for 8  hr or seeded directly 
on  C3H  fibroblast monolayers,  with  or without  3  /zg/ml  of hydrocortisone. 
It was found that  preincubation with  hydrocortisone  appeared to reduce by 
about 50 % the  total number of lymphocytes as well as the number of large 
lymphocytes, compared to sensitization cultures which were exposed to hydro- 
cortisone and sensitizing fibroblasts simultaneously (Table III). Nevertheless, 
the hydrocortisone-treated lymphocytes which survived preincubation demon- 
strated the same threefold increase in cytolytic activity as did treated lympho- 
cytes which  were not preincubated.  Preincubation  of lymphocytes in control 
medium had no effect on the number of recoverable cells. Three other similar 
experiments produced comparable results. 
Thus,  exposure  to  glucocorticoids  before exposure  to  antigen  appeared  to 1064  GLUCOCORTICOIDS  AND  CELLULAR  L3I[MUNITY  IN  VITRO 
reduce  the  final  numbers  of  sensitized  lymphocytes but  did  not  inhibit  the 
degree of sensitization of the surviving lymphocytes. 
The  Influence  of  Glucocorticoids  on  the  Effector  Phase  of  the  Lymphocyte 
Anti-fibroblast Reaction.--The  influence of glucocorticoids on the effector phase 
was studied by measuring the cytolytic activity and the number of sensitized 
lymphocytes during  the  lyric  reaction  in  the  presence  of  various  hormone 
concentrations. Table IV and Fig. 5 show the results of an experiment in which 
Lewis lymph node cells  which had been sensitized  against C3H fibroblasts in 
the absence of added glucocorticoids were incubated with target fibroblasts in 
medium which contained 0-1000/zg/ml of prednisolone. The presence of pred- 
TABLE IV 
Effects of Prednisolone on Number and Cytolytic Activity orSensitized Lymphocytes* 
No. of viable lymphocytes 
Prednisolone  (X 106) after lyric phase  Cytolysis of  Inhibition 
fibroblasts 
Total  Large cells 
,,g/m~  %  % 
0  2.8  i. 1  45  -- 
1  3.1  1.0  29  36 
I0  2.1  0.7  18  60 
100  1.5  0.4  17  62 
1000  O. 2  O. 04  2  96 
* Lewis lymph node cells were sensitized against C3H fibroblasts in the absence  of predniso- 
lone. The sensitized lymphocytes  were collected and 2.7 X 106 lymphocytes,  of which 0.8 X 
106 were large, were transferred for 22 hr to C3H target fibroblasts in EM containing predni- 
solone. 
nisolone at a  concentration of 1 /~g/ml  was associated with a  36 %  inhibition 
of lymphocyte-mediated cytolysis but no impairment of lymphocyte viability. 
To confirm this result we studied the effects  of prednisolone at concentrations 
of 0-20 /~g/ml.  Fig.  6  demonstrates  that  at  concentrations of 0.05-5  #g/ml 
there  was  no decrease,  and perhaps  even  a  significant  increase  (33 %  at 0.5 
#g/ml)  in  the  number  of  sensitized  lymphocytes at  the  termination  of  the 
cytolytic reaction.  Nevertheless,  prednisolone  at  concentrations  of  0.5,  1.0, 
and 5.0 #g/ml inhibited cytolytic activity by 25 %, 50%, and 67 % respectively. 
Prednisolone  at  a  concentration  of  20  /zg/ml  produced  a  36%  decrease  in 
lymphocyte number. 
Thus,  prednisolone  at  concentrations of about  1 /zg/ml suppressed  the  ef- 
fector phase of the lymphocyte anti-fibroblast reaction without demonstrating 
a significant lympholytic effect on previously sensitized lymphocytes. 
The  effects of hydrocortisone on the  effector phase  were  also studied  and 
found to be similar to those of prednisolone. IRITN R.  COHEN, LARY STAVY~ AND MICHAEL FELDMAN  1065 
The Effects  of Prednisolone  During Sensitization  and Lytic Reactions.--Ex- 
periments were done to test whether lymphocytes treated with glucocorticoids 
during induction would be resistant to their inhibitory effects on the cytolytic 
effector phase.  Table  V  shows  the  results  of  an  experiment  in  which  Lewis 
lymph  node  lymphocytes  were  sensitized  against  C3H  fibroblasts  with  or 
without  1  #g/ml  of  prednisolone.  After  the  sensitization  phase,  1.5  X  106 • 
÷IO 
o 
-IO 
-50 
c 
O 
-50 
a_  -70 
-90 
 oLymphoc, e number 
Cytolyhc octw,ty 
I  I  1 
oJ-// I  IO  IOO  IOOO 
Prednisolone  (p.g/ml) 
FIC. 5.  The influence of prednisolone (0-1000 #g/ml) on the  effector phase. Lewis rat 
lymph  node  cells were  sensitized against  C3H  mouse fibroblasts  and 2.7  )(  10  s of the 
sensitized lymphocytes  were incubated with  C3H  target  fibroblasts  in  the  presence  of 
0-1000 k~g/ml of prednisolone. Per cent lysis of fibroblasts and number of lymphocytes  were 
measured after 22 hr. Per cent change in lymphocyte number and cytolytic activity were com- 
puted by comparison with control cultures which were incubated without prednisolone. 
lymphocytes of both  kinds  were  incubated  for 20 hr with  C3H  target  fibro- 
blasts  with  or without  1 /zg/ml  of prednisolone.  It was  found  that  lympho- 
cytes which had been sensitized  in the presence of prednisolone demonstrated 
over twice the cytolytic activity of sensitized  control lymphocytes. Neverthe- 
less,  the  cytolytic  effects  of both  control  and  treated  lymphocytes were  in- 
hibited by about 50%  by the presence  of 1/zg/ml of prednisolone  during the 
cytolytic reaction.  Thus,  the  inhibitory effects  of glucocorticoids on lympho- 
cyte-mediated  cell injury were not  annulled  by the  presence  of prednisolone 
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DISCUSSION 
The in vitro lymphocyte anti-fibroblast reaction used in these studies may 
be considered to be a  model of cellular immunity. Small lymphocytes are in- 
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FIc. 6. The influence of prednisolone (0-20 #g/ml) on the effector phase. The conditions 
were the same as the experiment shown in Fig. 5, except that the prednisolone concentration 
was in the range of 0-20/zg/ml. 
TABLE  V 
E~ects ~PrednisoloneDuringSensitizationandLyticReactiom 
Sensitization phase*  Lytic phase:~ 
Lysis  Inhibition of lysis 
Prednisolone  Without prednisolone  Prednlsolone, 1 ~g/ml  by prednisolone 
~g/m~  %  %  % 
0  19  9  53 
1  42  20  52 
* 20 X  106 Lewis rat lymph node cells were sensitized against monolayers of C3H mouse 
fibroblasts in control medium and in medium containing 1 ~g/ml prednisolone. 
:~ 1.5 X  106 sensitized lymphocytes were incubated for 20 hr with C3H target monolay- 
ers with or without 1 ~g/ml of prednisolone. 
duced to transform into large cells through contact with antigenically foreign 
fibroblasts. These sensitized lymphocytes can be activated by the sensitizing 
antigens to  injure target  fibroblasts.  Extracellular  antibody or  complement 
have no demonstrable role in this reaction and close  contact between living IRUN  R.  COHEN,  LARY  STAVY,  AND  MICHAEL  FELDMAN  1067 
lymphocytes and target fibroblasts appears to be required for injury to occur 
(3, 4, 6). The lymphocyte anti-fibroblast reaction, therefore, provided a unique 
tool for observing the influence of glucocorticoids on the induction phase  as 
well as on the effector phase of a cellular immune response in vitro. 
The presence  of about  1 /zg/ml of hydrocortisone or prednisolone during 
induction resulted in a decrease in the total number of lymphocytes, but caused 
a  marked increase in the per cent of large transformed lymphocytes and in 
the cytolytic capacity of the sensitized lymphocytes. On the other hand, the 
presence of glucocorticoids during the effector phase was associated with an 
inhibition of lymphocyte-mediated lysis of target fibroblasts at concentrations 
of hormone which  did not impair  the viability of the previously sensitized 
lymphocytes. 
The influence of glucocorticoids on the induction phase can be explained by 
a  decreased  susceptibility to  the  lymphotoxic effects of  these  hormones  of 
transformed, sensitized lymphocytes compared to that of small lymphocytes. 
This is evidenced by the marked decrease in the number of small lymphocytes 
at  the  beginning  of  induction and  the  apparent  proliferation of  sensitized 
lymphocytes in the latter stage  of induction which was  accentuated in the 
presence of hydrocortisone (Fig. 3). Thus, contact with sensitizing fibroblasts 
might initiate changes in specifically reactive lymphocytes which lead to both 
transformation and resistance to glucocorticoid toxicity. Those small lympho- 
cytes which are not capable of induction by contact with the sensitizing fibro- 
blasts would remain vulnerable to the toxic effects of the hormones. It has been 
shown  that  glucocorticoids  inhibit  protein  synthesis  and  DNA  and  RNA 
metabolism of small unsensitized rat lymphocytes (8).  In preliminary studies 
we  have  found however  that  synthesis of protein  and DNA  by sensitized 
lymphocytes is unimpaired, at least during 24 hr of incubation, by comparable 
concentrations of hormones.  ~ Thus, glucocorticoids may act to select antigen- 
reactive lymphocytes from among the initial lymphocyte population. 
The effects on sensitization of nonglucocorticoid immunosuppressive agents 
such as azathioprine have been studied by employing the same in vitro cell 
culture system? It was found that the presence of azathioprine also led to a 
profound decrease  in  the  number  of recoverable  lymphocytes. However,  in 
contrast to the selective action of glucocorticoids, azathioprine-treated lympho- 
cytes were unable  to injure  target fibroblasts  after the  drug  was removed. 
In the absence of glucocorticoids a relatively larger number of lymphocytes 
which are not sensitized appear to survive the induction phase. Some of these 
unsensitized lymphocytes may be  transformed into large cells  by mitogenic 
substances released by sensitized lymphocytes (9).  Hence, at the end of the 
induction phase a smaller fraction of the large lymphocytes in control cultures 
2 Stavy, L., I. R. Cohen, and M. Feldman.  Unpublished results. 
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may be  specifically active against target fibroblasts.  This  could explain the 
apparent increase in cytolytic activity per large cell observed after sensitiza- 
tion in the presence of hydrocortisone (Table II). 
Preincubating small lylnphocytes with hydrocortisone before exposing them 
to sensitizing fibroblasts led to a  decrease in the yield of sensitized cells but 
did not impair their augmented cytolytic activity (Table III).  It is possible 
that some of the potentially reactive lymphocyte population may have been 
irreversibly damaged by preincubation with hydrocortisone for 8 hr.  Subse- 
quent  interaction  of  the  surviving  lymphocytes with  sensitizing fibroblasts 
may have initiated cellular changes leading to the transformation of the re- 
maining potentially reactive lymphocytes. These findings suggest that gluco- 
corticoids may eliminate small lymphocytes randomly in the absence of sensi- 
tizing antigens. 
It has been shown that the effector phase of the lymphocyte anti-fibroblast 
reaction involves at least two stages (6).  The first stage comprises activation 
by antigen of the effector mechanism of the sensitized lymphocytes. Recogni- 
tion of antigen by a receptor on the surface of the lymphocyte would appear 
to initiate this reaction. The second stage may be considered to be the cytolytic 
process itself. This stage is not antigen-specific since lymphocytes activated by 
antigen may inflict damage upon any fibroblast with which contact is made. 
Inhibition of target-cell injury by glucocorticoids might therefore result from 
interference with either or both stages of the effector phase. It is  not  likely, 
however, that glucocorticoids block the recognition of antigen by lymphocytes. 
Rosenau  and  Moon  have  demonstrated  (10)  that  hydrocortisone prevents 
cytolysis of target cells without inhibiting antigen-specific clustering of lympho- 
cytes about the target cells. In addition, our finding that sensitization occurs 
in the presence of glucocorticoids suggests that the ability of lymphocytes to 
interact with antigen persists. It is likely therefore that glucocorticoids inhibit 
the effector mechanism of transformed lymphocytes at a  stage distal to the 
interaction of the receptor with antigen. The nature of the effector mechanism 
is unknown. However, glucocorticoids have been shown to stabilize lysosome 
membranes (11) and it is conceivable that lysosomal enzymes might have some 
role in target-cell injury as well as in lymphocyte activation (12, 13). 
It is quite possible that our results pertain only to rat lymphocytes in an 
in  vitro  experimental system. Nevertheless,  it might be useful to relate  our 
in vitro findings to cellular immunity in vivo in view of the wide clinical use 
of glucocorticoid hormones as immunosuppressive agents. 
Despite the fact that glucocorticoids may act to reduce the total number of 
small lymphocytes, the immune process of sensitization itself may evolve un- 
hindered or may even be facilitated by glucocorticoids in vivo as it is in vitro. 
The development of specifically sensitized lymphocytes might not be recog- 
nized as long as glucocorticoids are present to inhibit damage to target cells. ]:RUN  R.  COHEN,  LARY  STAVY,  AND  MICHAEL  FELDMAN  1069 
Therefore,  it  appears  questionable  whether  glucocorticoid  hormones  ought 
to  be  used  routinely  to  suppress  lymphocyte-mediated immune  reactions 
during  the period  of primary sensitization.  Our findings,  however,  support 
the use  of glucocorticoids as  agents  to suppress  tissue  damage mediated by 
lymphocytes which  already have been  sensitized.  Glucocorticoids  could also 
be used to reduce the number of potentially reactive lymphocytes by treating 
graft recipients, for example, before the foreign graft is applied. Glucocorticoid 
treatment shoutd be  stopped,  however,  when the patient first receives  the 
foreign graft. 
Additional practical applications of the results of our studies involve the use 
of  glucecorticoids  to  promote  the  development  in  vitro  of  populations  of 
lymphoc3/tes which exhibit a high degree of specific sensitization.  We are cur- 
rently studying aspects of transplantation and tumor immunity by sensitizing 
lymphocytes to tissue antigens with the aid of glucocorticoids in vitro (14). 
SUMMARY 
We studied the influence of glucocorticoids  on  the sensitization  phase  as 
well as  on the cytolytic effector phase  of an in vitro lymphocyte-mediated 
immune reaction.  Lymphocytes obtained from the spleens or lymph nodes of 
unimmunized inbred rats were  sensitized  against foreign  rat  or  mouse  em- 
bryonic fibroblasts in cell culture.  The capacity of the sensitized lyrnphocytes 
to produce  a cytolytic effect was tested by transferring  them to target fibre- 
blast cultures.  Injury to target fibroblasts  was measured by release of radio- 
active 51Cr from previously labeled  fibroblasts  or  by direct  count of viable 
fibroblasts  after incubation with sensitized  lymphocytes. Various  concentra- 
tions of water-soluble  hydrocortisone  or prednisolone were added to cell cul- 
tures during the 5 day sensitization phase and/or during the subsequent  cyto- 
lyric effector phase  and the influence of these  hormones  on the number and 
cytolytic capacity of the lymphocytes was measured. 
During the sensitization  phase,  the presence of glucocorticoid hormones, at 
concentrations  of about 1 #g/ml, led to a profound decrease in the total num- 
ber of recoverable  lymphocytes. However,  the per cent of large transformed 
lymphocytes was much greater in these treated cultures.  The antigen-specific 
cytolytic capacity per ceil of the glucocorticoid-treated  lymphocytes, after the 
hormone  was  removed,  was  several  times greater than that of lymphocytes 
sensitized in the absence of added hormones. 
Glucocorticoids influenced the effector phase  of the reaction by inhibiting 
lymphocyte-mediated injury to target fibroblasts.  The hormones,  at concen- 
trations of about 1 #g/ml, inhibited the cytolytic effect by about 50 % without 
reducing the viability of the sensitized lymphocytes. Dose-dependent toxicity 
to lymphocytes and increasing inhibition of cytolytic effect appeared at higher 
concentrations of hormones. 1070  GLUCOCORTICOIDS  AND  CELLULAR  IMMUNITY  IN  VITRO 
Thus, hydrocortisone and prednisolone, at concentrations of about 1 #g/ml, 
did not suppress the induction of sensitization, a  process which  they seem to 
facilitate in vitro. However, similar concentrations of these hormones  appear 
to  inhibit the  cytolytic effector mechanism  of sensitized lymphocytes. These 
findings may be relevant to  the use of glucocorticoids as immunosuppressive 
agents in viva. 
We thank Dr. Joseph Blum  for developing  a mathematical model of our results which 
greatly aided our understanding and interpretation of the findings, and Mr. Zion Gedassi for 
his expert technical assistance. 
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